Rooted in Collaboration with Leaders in Science and Health
How MediChip™ Works
.svg)
MediChip™ is designed to interface directly with solid tumors across multiple anatomical sites.
MediChip™ is designed to interface directly with solid tumors across multiple anatomical sites.
MediChip™ is designed to interface directly with solid tumors across multiple anatomical sites.
MediChip™ is designed to interface directly with solid tumors across multiple anatomical sites.
Why Localized Delivery?
Systemic delivery limits the dose.
Local placement changes the equation.
The platform is agent-agnostic.
.svg)
Platform Advantages
Lower GI Cancers
Our current focus is lower GI cancers (colorectal), where MediChip™ has demonstrated strong preclinical performance. The platform's adaptability positions it for expansion across multiple oncology indications.
Future Platform Opportunities
Oncology
Where the platform is being actively evaluated.
Animal Health
Mention exploration without making it feel like a second company.
Future Expansion Opportunities
Where the platform is being actively evaluated.
Frequently Asked Questions
MediChip™ is BioSapien's biodegradable, 3D-printed implant designed to deliver cancer therapy directly at the tumor bed. It provides sustained, localized drug delivery from a single placement.
MediChip™ is designed to release therapy over 28 days from a single placement. The implant is biodegradable and is designed to break down naturally, eliminating the need for surgical removal.
MediChip™ is designed to accommodate a range of therapeutic drugs rather than being limited to a single agent. Its delivery platform can be adapted for different therapeutic applications.
Yes. MediChip™ is a biodegradable implant designed to gradually break down after placement, eliminating the need for surgical removal.
BioSapien's current focus is colorectal cancer. MediChip™ is designed as an adaptable platform with the potential for future applications across other solid tumors.
Systemic chemotherapy circulates throughout the body, which can expose healthy tissues to treatment and limit the dose patients can tolerate. MediChip™ is designed to deliver therapy directly at the tumor bed, providing sustained local drug release while reducing exposure elsewhere in the body.
.png)
.png)
Help shape the future of localizedcancer therapy.
Whether you're a pharmaceutical company, research institution, clinical investigator, or strategic partner, we're building the next generation of localized oncology treatments together.
.avif)